CN Patent

CN101129381B — 含β-内酰胺类抗生素和离子螯合剂的抗生素复方

Assigned to Ganzhou Hemay Pharmaceutical Co Ltd · Expires 2012-02-01 · 14y expired

What this patent protects

本发明名称为含β-内酰胺类抗生素和离子螯合剂的抗生素复方，公开含有至少一种β-内酰胺类抗生素和至少一种能抑制颗粒生成的离子螯合剂组成的抗生素复方，该复方可进一步加入至少一种β-内酰胺酶抑制剂或缓冲组分，或同时加至少一种β-内酰胺酶抑制剂和缓冲组分，该复方的特点是可配成稳定的溶液制剂，并可与至少一种氨基糖苷类抗生素在同一容器中复配成溶液制剂用作控制微生物感染药物。

USPTO Abstract

本发明名称为含β-内酰胺类抗生素和离子螯合剂的抗生素复方，公开含有至少一种β-内酰胺类抗生素和至少一种能抑制颗粒生成的离子螯合剂组成的抗生素复方，该复方可进一步加入至少一种β-内酰胺酶抑制剂或缓冲组分，或同时加至少一种β-内酰胺酶抑制剂和缓冲组分，该复方的特点是可配成稳定的溶液制剂，并可与至少一种氨基糖苷类抗生素在同一容器中复配成溶液制剂用作控制微生物感染药物。

Drugs covered by this patent

Patent Metadata

Patent number: CN101129381B
Jurisdiction: CN
Classification: —
Expires: 2012-02-01
Drug substance claim: No
Drug product claim: No
Assignee: Ganzhou Hemay Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.